Bank Of New York Mellon Corp Seelos Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.66 - $259.46 $34,881 - $13.7 Million	52,850 New	52,850 $35,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $1,387 - $594,981	-2,135 Reduced 3.88%	52,850 $54,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $120,413 - $219,577	-236,105 Reduced 81.11%	54,985 $37,000
Q4 2021 Feb 11, 2022	BUY	$1.59 - $2.38 $75,046 - $112,333	47,199 Added 19.35%	291,090 $475,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $121,066 - $207,030	71,637 Added 41.59%	243,891 $588,000
Q2 2021 Aug 11, 2021	BUY	$2.64 - $6.32 $387,066 - $926,613	146,616 Added 571.87%	172,254 $454,000
Q1 2021 May 13, 2021	SELL	$1.35 - $4.99 $27,743 - $102,549	-20,551 Reduced 44.49%	25,638 $127,000
Q4 2020 Feb 09, 2021	BUY	$0.74 - $2.01 $34,179 - $92,839	46,189 New	46,189 $72,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.